0001493152-22-015068.txt : 20220525
0001493152-22-015068.hdr.sgml : 20220525
20220525172044
ACCESSION NUMBER: 0001493152-22-015068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220523
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karkus Ted William
CENTRAL INDEX KEY: 0001457896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 22964189
MAIL ADDRESS:
STREET 1: 188 HEWLETT NECK ROAD
CITY: WOODMERE
STATE: NY
ZIP: 11598
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2022-05-23
0
0000868278
ProPhase Labs, Inc.
PRPH
0001457896
Karkus Ted William
711 STEWART AVE,
SUITE 200
GARDEN CITY,
NY
11530
1
1
1
0
CEO & CHAIRMAN
Common Stock, par value $0.005
2022-05-23
4
M
0
450000
2.00
A
2783471
D
Common Stock, par value $0.005
2022-05-23
4
F
0
278257
8.47
D
2505214
D
Common Stock, par value $0.005
100000
I
By Son
Option (right to buy)
2.00
2022-05-23
4
M
0
450000
0.00
D
2024-04-27
Common Stock
450000
0
D
On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes.
The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.
/s/ Ted Karkus
2022-05-25